Cargando…
Soluble HLA peptidome: A new resource for cancer biomarkers
Using circulating molecular biomarkers to screen for cancer and other debilitating disorders in a high-throughput and low-cost fashion is becoming increasingly attractive in medicine. One major limitation of investigating protein biomarkers in body fluids is that only one-fourth of the entire proteo...
Autores principales: | Tanuwidjaya, Erwin, Schittenhelm, Ralf B., Faridi, Pouya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815702/ https://www.ncbi.nlm.nih.gov/pubmed/36620582 http://dx.doi.org/10.3389/fonc.2022.1069635 |
Ejemplares similares
-
Soluble HLA peptidome of pleural effusions is a valuable source for tumor antigens
por: Khazan-Kost, Sofia, et al.
Publicado: (2022) -
High-throughput characterization of the ovarian cancer HLA peptidome
por: Patterson, Andrea, et al.
Publicado: (2014) -
HLA-I and HLA-II Peptidomes of SARS-CoV-2: A Review
por: Abd El-Baky, Nawal, et al.
Publicado: (2023) -
The Process Chain for Peptidomic Biomarker Discovery
por: Schrader, Michael, et al.
Publicado: (2006) -
Urinary Peptidomic Biomarkers in Kidney Diseases
por: Sirolli, Vittorio, et al.
Publicado: (2019)